Trials / Recruiting
RecruitingNCT06343051
USCOM in Newly Diagnosed FGR Cases
Ultrasound Hemodynamic Assessment in Newly Diagnosed Fetal Growth Restriction: A Pilot Study
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Icahn School of Medicine at Mount Sinai · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this research study is to study the use of an ultrasound measurement system (USCOM) for patients with newly diagnosed fetal growth restriction (FGR). This system uses a technology to measure how much blood is being pumped in and out of the heart, which is important for understanding the heart's function in relation to pregnancy.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | USCOM | Device that measures how much blood is being pumped in and out of the heart. |
Timeline
- Start date
- 2024-07-02
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2024-04-02
- Last updated
- 2025-02-10
Locations
1 site across 1 country: United States
Regulatory
- FDA-regulated device study
Source: ClinicalTrials.gov record NCT06343051. Inclusion in this directory is not an endorsement.